# Gene Therapy for Chinese Hemophilia A

> **NCT04728841** · NA · RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 12 (estimated)

## Conditions studied

- Hemophilia A
- Gene Therapy

## Interventions

- **GENETIC:** Injection of GS001

## Key facts

- **NCT ID:** NCT04728841
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-04
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04728841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04728841, "Gene Therapy for Chinese Hemophilia A". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04728841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*